'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence

HIV Medicine

Volumn 7, Issue 5, 2006, Pages 285-290

  Barfod, Toke S ^a   Sorensen H T ^b   Nielsen, H ^c   Rodkjaer L ^b   Obel, N ^d  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Highly active antiretroviral therapy; HIV; Patient compliance; Patient nonadherence; Questionnaire

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; DRUG DOSE REGIMEN; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF EVALUATION; SELF REPORT; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DENMARK; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SELF DISCLOSURE; TREATMENT REFUSAL;

EID: 33744484579     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2006.00387.x     Document Type: Article

References (23)

1. Poppa A, Davidson O, Deutsch J et al. British HIV Association (BHIVA)/ British Association for Sexual Health and HIV (BASHH) guidelines on provision of adherence support to individuals receiving antiretroviral therapy (2003). HIV Med 2004; 5 (Suppl. 2): 46-60.
2. Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy: Lessons from research and clinical practice. Clin Infect Dis 2001; 33: 865-872.
3. Maggiolo F, Ripamonti D, Arici C et al. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients. HIV Clin Trials 2002; 3: 371-378.
4. Paech V, Lorenzen T, Stoehr A, Plettenberg A. Adherence to HAART: Why is it so difficult? Arch Intern Med 2002; 162: 1197-1198.
5. Reynolds NR, Testa MA, Marc LG et al. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: A multicenter, cross-sectional study. AIDS Behav 2004; 8: 141-150.
6. Simoni JM, Frick PA, Lockhart D, Liebovitz D. Mediators of social support and antiretroviral adherence among an indigent population in New York City. AIDS Patient Care STDS 2002; 16: 431-439.
7. Stout BD, Leon MP, Niccolai LM. Nonadherence to antiretroviral therapy in HIV-positive patients in Costa Rica. AIDS Patient Care STDS 2004; 18: 297-304.
8. Molassiotis A, Nahas-Lopez V, Chung WY, Lam SW, Li CK, Lau TF. Factors associated with adherence to antiretroviral medication in HIV-infected patients. Int J STD AIDS 2002; 13: 301-310.
9. O'Brien ME, Clark RA, Besch CL, Myers L, Kissinger P. Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort. J Acquir Immune Defic Syndr 2003; 34: 407-414.
10. Roege BT, Barfod T, Kirk O et al. Resistance profiles and adherence at primary viral failure in three different HAART regimes: Analysis of failures within two randomised studies. HIV Med 2004; 5: 344-351.
11. Mannheimer S, Morse E, Matts J et al. Sustained benefit from a long-term antiretroviral (AR) adherence intervention: Results of a large randomized clinical trial, XV. International AIDS Conference. Bangkok, Thailand, July 2004 [Abstract LbOrB15].
12. Graney MJ, Bunting SM, Russell CK. HIV/AIDS medication adherence factors: Inner-city clinic patient's self-reports. Tenn Med 2003; 96: 73-78.
13. Barfod T, Gerstoft J, Rodkjær L et al. Patients' answers to simple questions about treatment satisfaction and adherence, and depression are associated with failure of HAART. A cross-sectional survey. AIDS Patient Care STDS 2005; 19: 317-325.
14. Chesney MA, Ickovics JR, Chambers DB et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care 2000; 12: 255-266.
15. Barfod TS. Adherence to HIV treatment -patient perceptions and physician communication studied by observation, interviews, questionnaires, and patients' files. PhD thesis. Copenhagen, Denmark, Department of Infectious Diseases, Rigshospitalet, and Faculty of Health Sciences, University of Copenhagen, 2005.
16. Drennan J. Cognitive interviewing: Verbal data in the design and pretesting of questionnaires. J Adv Nurs 2003; 42: 57-63.
17. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med 2002; 137: 381-433.
18. Johnson MO, Catz SL, Remien RH et al. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the Healthy Living Project. AIDS Patient Care STDS 2003; 17: 645-656.
19. Walsh JC, Horne R, Dalton M, Burgess AP, Gazzard BG. Reasons for non-adherence to antiretroviral therapy: Patients' perspectives provide evidence of multiple causes. AIDS Care 2001; 13: 709-720.
20. Weidle PJ, Ganea CE, Irwin KL et al. Adherence to antiretroviral medications in an inner-city population. J Acquir Immune Defic Syndr 1999; 22: 498-502.
21. Altman DG. Practical Statistics for Medical Research, 1st edn. London, UK: Chapman & Hall, 1991.
22. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: Three decades of research. A comprehensive review. J Clin Pharm Ther 2001; 26: 331-342.
23. Barfod TS, Rubow C, Hecht FM, Gerstoft J. An observational and qualitative interview study of physician's communication with HIV-patients about medication adherence in San Francisco and Copenhagen, XV. International AIDS Conference. Bangkok, Thailand, July 2004 [Poster WePeB5834].